Brief: Centessa Pharmaceuticals Announces Addition To Nasdaq Biotechnology Index
13/12/2021 22:42
Dec 13 (Reuters) - Centessa Pharmaceuticals PLC 260y.F :
* CENTESSA PHARMACEUTICALS ANNOUNCES ADDITION TO NASDAQ
BIOTECHNOLOGY INDEX
Source text for Eikon: ID:nGNX3C0MQn
Further company coverage: 260y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Centessa Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Acquisition Of Centessa By Lilly Approved By The High Court Of Justice Of England And Wales
Street View: Lilly's $7.8 billion Centessa buyout validates sleep‑drug market
Press Digest: New York Times business news - April 1